Therapeutic efficacy of mirabegron 25 mg monotherapy in patients with nocturia-predominant hypersensitive bladder

OBJECTIVE: The objective of this study was to evaluate the efficacy of mirabegron 25 mg daily in patients with nocturia-predominant hypersensitive bladder (HSB). MATERIALS AND METHODS: This study prospectively investigated 219 consecutive patients with nocturia-predominant HSB and treated with mirab...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Cheng-Ling, Ong, Hueih-Ling, Kuo, Hann-Chorng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015015/
https://www.ncbi.nlm.nih.gov/pubmed/32110517
http://dx.doi.org/10.4103/tcmj.tcmj_226_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015015/
https://www.ncbi.nlm.nih.gov/pubmed/32110517
http://dx.doi.org/10.4103/tcmj.tcmj_226_18

Ejemplares similares